Add like
Add dislike
Add to saved papers

Assessment of quinoxyfen phototransformation pathways by liquid chromatography coupled to accurate mass spectrometry.

Quinoxyfen has been recently identified as a priority hazardous substance in the field of the European water policy. In this work, its fate in aqueous samples and solid supports under UV and solar radiation is investigated. Diverse degradation experiments were carried out, at lab scale, using spiked aliquots of different aqueous matrices (ultrapure, treated wastewater and river water) irradiated at different wavelengths (λ = 254 nm, λ = 365 nm and solar light). Half-lives of quinoxyfen (2-26 min) depended on the wavelength and the intensity of radiation whilst the nature of the aqueous matrix did not play an important role in degradation kinetics. Moreover, experiments under solar radiation of doped silicone tubes were performed to simulate degradation when quinoxyfen is adsorbed on plant leaves or soil. As the compound is not completely mineralized, the identification of quinoxyfen transformation products (TPs) was performed by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) injection of different irradiated time aliquots. The full-fragment ion spectra, at different collision energies, allowed the elucidation of the chemical structure of TPs formed by hydroxylation, cyclization or cleavage reactions. Five out of seven identified TPs have not been reported previously. The ecotoxicity simulation by software (TEST and ECOSAR) for TPs revealed that some of them could cause harmful effects to organisms such as Daphnia magna or Fathead minnow in a similar extent to the precursor; moreover, the time course profiles of major TPs (TP1 and TP2) revealed a much higher resistance to further photodegradation than quinoxyfen. Graphical abstract Quinoxyfen phototransformation pathways.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app